Piper Sandler Maintains AVITA Medical (RCEL) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 11, 2023, Piper Sandler maintained coverage of AVITA Medical (NASDAQ:RCEL) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2140836981-6aef1133ffe24ca1ae9ea20dcb1ea89c.jpg "Net Neutrality Issue (Again): Pros and Cons")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-520916962-a17c611737b8484ba4c5d6e2a7fdffdc.jpg "Is Google a Good Investment?")
:max_bytes(150000):strip_icc():format(jpeg)/Price-to-EarningsRatio_final-23bff9e93e624fdea7eb34ec993ea8a9.png "<div>Where Can I Find the P/E Ratios for the Dow and S&P 500?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/TypesofPersonalLoanLenders-32f64366eee441288bbf08fc11da6051.jpg "Which Lenders Have the Lowest Home Equity Loan Rates?")
:max_bytes(150000):strip_icc():format(jpeg)/Leveraged-Buyout-V2-e108bff825ab4892afd2f22c7aa7b088.jpg "How Are Leveraged Buyouts Financed?")